News AstraZeneca PLC

Equities

AZN

GB0009895292

Real-time Estimate Cboe Europe Other stock markets 03:33:32 2024-05-08 am EDT			5-day change	1st Jan Change
12,292 ^GBX	+1.44%		+0.81%	+15.74%

09:19am	AstraZeneca lifts FTSE 100 to record high; BOE rate decision on tap	RE
05:43am	AstraZeneca to Remove COVID-19 Jab from EU Markets Due to Commercial Reasons	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AstraZeneca lifts FTSE 100 to record high; BOE rate decision on tap	03:19am	RE
AstraZeneca to Remove COVID-19 Jab from EU Markets Due to Commercial Reasons	11:43pm	MT
AstraZeneca to withdraw COVID-19 vaccine globally, Telegraph reports	May. 07	RE
AstraZeneca to withdraw Covid vaccine worldwide, The Telegraph reports	May. 07	RE
The Oxford-Astrazeneca COVID Vaccine Is Being Withdrawn Worldwide- The Telegraph	May. 07	RE
THE OXFORD-ASTRAZENECA COVID VACCINE IS BEING WITHDRAWN WORL…	May. 07	RE
Berenberg Raises AstraZeneca PT, Keeps Rating at Buy	May. 07	MT
ASTRAZENECA : Berenberg keeps its Buy rating	May. 07	ZD
AstraZeneca target raised; Antofagasta lowered	May. 07	AN
BP starts USD1.75 billion share buyback scheme	May. 07	AN
ANGLE PLC - NEW COMMERCIAL AGREEMENT WITH LARGE PHARMA	May. 06	AQ
Cellectis: alliance with AstraZeneca finalized	May. 06	CF
Cellectis Secures $140 Million Additional Equity Investment From AstraZeneca	May. 06	MT
AstraZeneca: equity investment in Cellectis	May. 06	CF
AstraZeneca completes collaboration and investment deal with Cellectis	May. 06	AN
AstraZeneca Secures 44% Stake in French Biotech Cellectis	May. 06	MT
Combination treatment could provide new standard-of-care for aggressive lymphoma	May. 03	AQ
AI Startup Fileread Names Former AstraZeneca Legal Leader as Chief Strategy Officer and General Counsel to Drive Product Development and Accelerate Growth	May. 03	AQ
Angle shares up on assay development deal with AstraZeneca	May. 03	AN
Astrazeneca - CALQUENCE combination regimen demonstrated statistically significant and clinically meaningful improvement in progression-free survival in 1st-line mantle cell lymphoma in ECHO Phase III trial	May. 03	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ASTRAZENECA : Strong Q1 raises hopes of a guidance upgrade

April 25, 2024 at 12:02 pm EDT